Background: Effective pulmonary blood flow (CO EPBF ) has recently been validated as a technique for determining cardiac output (CO) in animals of varying sizes. The primary aim of our study was to investigate this new technique in paediatric surgical patients, compared with suprasternal two-dimensional Doppler (CO SSD ). Methods: A total of 15 children undergoing cleft lip/palate surgery were investigated. Before the start of surgery, manoeuvres that were anticipated to reduce (increase in PEEP from 3 to 10 cm H 2 O) and increase (atropine) CO were undertaken. A study in mechanically ventilated piglets was also undertaken under general anaesthesia, measuring CO EPBF and pulmonary artery (CO TS ) flow by ultrasonic probe as the comparator. Bias (BlandÀAltman plots) and limits of agreement were assessed for effective pulmonary blood flow and CO SSD or CO TS . Results: In paediatric patients (median age 8.5 months), overall bias was À8.1 (limits of agreement À82 to þ66) ml kg À1 min
Editor's key points
Effective pulmonary blood flow (CO EPBF ) is a validated, non-invasive technique for determining cardiac output (CO) in small, mechanically ventilated animals. Routine measurement of CO in anaesthetised paediatric patients is limited by technological constraints and the avoidance of invasive techniques. This study shows high concordance between CO EPBF and the gold standard measurement of pulmonary blood flow (by ultrasonic flow probe) in anaesthetised, mechanically ventilated piglets. In the paediatric clinical setting, the authors also showed that CO EPBF detected CO changes in mechanically ventilated, anaesthetised children.
The ability to monitor cardiac output (CO) is of great interest in many medical specialties, but is of specific importance in the context of anaesthesia and intensive care. In the adult setting, a variety of techniques have been advocated to monitor CO, but all have significant limitations when applied clinically. This is perhaps even more apparent in infants and small children, as many techniques cannot be safely used or suffer from paediatric-specific constraints.
1 Furthermore, few of these techniques have been validated in infants and children. 2 The continuous capnodynamic approach to determine CO (effective pulmonary blood flow, CO EPBF ) in intubated, mechanically ventilated patients, has recently been validated in porcine experiments. 3e5 Studies of previous CO 2 based CO measurement techniques have found the methods to be in acceptable agreement with gold standard comparators (e.g. pulmonary artery catheter thermodilution) and associated with excellent trending characteristics. 6e9 However, the CO EPBF method has not been studied in the clinical setting. The primary aim of the present study was to compare the performance of CO EPBF in children undergoing anaesthesia with a clinically accepted measure [suprasternal twodimensional (2D) Doppler CO].
10e12 A porcine study was also undertaken to further explore this clinical protocol, using an ultrasonic flow probe as the gold standard measure of pulmonary artery blood flow. 13 
Methods

Clinical investigation
Study protocol
After a 5-min stabilisation period following tracheal intubation, the study sequence was performed ( Fig. 1 ):
(i) Three baseline CO measurements were performed 1 min apart. CO SSD and CO EPBF were recorded simultaneously. (ii) To reduce CO, PEEP was then increased from 3 to 10 cm H 2 O. CO measurements were performed at 1, 3, and 5 min after the PEEP increase. (iii) Further recordings of CO were undertaken at 1 and 3 min after PEEP had been restored to 3 cm H 2 O. (iv) To increase CO, the patients were then given an i.v. bolus of atropine 20 mg kg À1 which is part of the standard anaesthetic for these patients. CO EPBF and CO SSD were then recorded 1, 3, and 5 min after atropine administration, which completed the experimental protocol. Thereafter, anaesthesia and surgery continued according to routine clinical management.
Cardiac output measurements
CO EPBF
CO EPBF was measured continuously, as described by H€ allsj€ o and colleagues 3 using the differential Fick's principle. The continuous method is based on the molar balance for CO 2 as described in Equation (1):
(1) 14 This change in alveolar CO 2 concentration and elimination is proportional to the alveolar blood flow, as described in Equation (1) . Each breathing analysis sequence consists of nine breaths. Every breath creates a new separate equation. Thus, nine breaths generate nine equations with three unknown variables (EPBF, ELV, C v CO 2 ). By optimising the fit between the lung model and measured data, the equation system described above can be solved. In the absence of major cardiac or pulmonary shunting, CO EPBF will be closely related to pulmonary blood flow and thus systemic CO. 15 Haemoglobin, which is required for calculating CO EPBF , was measured using a HemoCue ® Hb 201þ (Hemoque AB, Angelholm, Sweden).
CO SSD
CO SSD has been evaluated for adult and paediatric patients by comparing it with a variety of reference methods 16, 17 and has been used extensively in various clinical settings. 18, 19 CO SSD was measured in every patient by a single, highly experienced sonographer (P.W.) using the supra-sternal Doppler measurement technique. Measurements were made using a Philips ultrasound system (Philips CX 50, Philips Healthcare, Andover, MA, USA). The CO SSD operator was blinded to CO EPBF values measured. After establishing a satisfactory quality 2D parasternal long axis view, the aortic diameter was measured at the aortic valve annulus. Two consecutive aortic diameter measurements were made and the mean of the two values was used for absolute CO calculation. To minimise error in angulation, the ascending aorta was insonated from the jugular notch using 2D and colour Doppler. 20 The flow velocity was measured with pulsed Doppler and the sample volume placed just above the aortic valve. Care was taken to search the highest velocity and after a stable Doppler signal was obtained, the velocity time integral (VTI) was recorded over 6e12 consecutive beats (mean eight) with no specific timing to any of the sections of the breathing cycle described previously in Equation (1). The mean VTI for one beat was then multiplied by the aortic valve area and the heart rate to obtain CO. , FIO 2 0.4 and PEEP 5 cm H 2 O. A balloon-tipped 7.5 Fr pulmonary artery catheter was inserted via the right jugular vein into the pulmonary artery. The jugular vein and carotid artery were cannulated for pressure recordings and blood sampling. A urinary Foley catheter was inserted into the urinary bladder. Through a left sided thoracotomy, an ultrasonic flow probe was placed around the pulmonary trunk for continuous measurement of CO TS . The chest was thereafter closed and the animals positioned in a supine position. Lung recruitment was performed using a peak pressure of 20 H 2 O, PEEP 10 cm H 2 O with I:E 1:1, and a ventilatory frequency of 10 for 2 min. The body temperature was maintained at 38e39 C. Pressure readings and signals from the ultrasonic flow probe were sampled into a data acquisition system (version 3.2.7, Acknowledge, BioPac Systems, Santa Barbara, CA, USA).
Laboratory animal investigation
After instrumentation, and a 15-min stabilisation period, the piglets underwent the same protocol as that used in the clinical study. However, the piglets required a higher single dose of i.v. atropine (40 mg kg À1 ) to increase CO, based on previous studies in the host laboratory. After the end of the study protocol, the piglets were euthanised humanely according to an established procedure at the laboratory, in accordance with local ethical approval guidelines. 
Cardiac output measurements
CO EPBF was measured as described in the clinical part of the study. CO TS was measured using an ultrasonic flow probe (AUseries COnfidence Flowprobe ® with ultrafit circle liner, Transonic System, Inc., Ithaca, NY, USA), in accordance with the instructions from the manufacturer (T401; Transonic System, Inc.). A filter of 0.1 Hz was used to display the mean CO TS over 10 s. A mean percentage error less or equal to 30% was defined a priori to indicate clinical useful reliability of EPBF as compared with the reference method, as previously described. 25 The ability of CO EPBF to track changes in CO was assessed by calculating the concordance (the proportion of measurements that change in the same direction when two techniques are compared) for CO EPBF in both experimental (CO TS ) and clinical (CO SSD ) protocols. In both studies, the changes in CO were calculated from the last paired measurements in the hemodynamic interventions: i.e. between baseline 1 at PEEP 3 cm H 2 O and PEEP 10 cm H 2 O after 5 min and baseline 2 PEEP 3 cm H 2 O after 3 min and atropine after 5 min. As no general consensus exists regarding which exclusion zones to use in paediatric CO monitoring when examining concordance, an exclusion zone of 10% was chosen, extrapolated from the precision of the reference methods. 26 
Statistical analysis
Results
Clinical investigation
Fifteen children of both sexes were included in the study, with a median age of 8.5 months (range 6e23 months) and median weight 8.3 kg (range 7.8e10.5 kg).
Calculated inherent precision
The calculated inherent precision at baseline was ±4% and ±12% for CO EPBF and CO SSD, respectively.
Changes in cardiac output (Table 1 and Fig. 2) For further analysis of agreement, data were sub-grouped into baseline, low CO (PEEP 10 cm H 2 O after 5 min), second baseline (PEEP 3 cm H 2 O after 3 min) and high CO (atropine after 5 min). The changes in CO EPBF and CO SSD in response to the hemodynamic challenges are shown in Fig. 2 .
Agreement of absolute values
Paired data from all interventions are plotted in Fig. 3 . BlandÀAltman analysis for all paired data demonstrated a mean bias between CO SSD and CO EPBF of 8.1 ml kg À1 min
À1
, with 95% limits of agreement of À82 to þ 66 ml kg À1 min À1 , and a mean percentage error of 48%. The overall CO EPBF concordance with CO SSD was 64%.
Experimental porcine model
All animals survived the experiment. The calculated inherent precision over 10 paired baseline measurements were ±6% and ±4% for CO EPBF 
Agreement of absolute values CO EPBF and CO TS
BlandÀAltman analysis for all paired data showed agreement of mean bias between CO EPBF and CO TS of 18 ml kg À1 min
À1
, with 95% limits agreement of À36 to þ 38 ml kg À1 min À1 , and a mean percentage error of 31%. A BlandÀAltman plot of paired data from all interventions is shown in Fig. 4 . Data were further grouped into baseline, PEEP 10 cm H 2 O after 5 min, PEEP 3 cm H 2 O after 3 min, and atropine after 5 min, and agreement and mean percentage error was determined for each group (Table 1) . The concordance between CO EPBF and CO TS was 95% (Fig. 5) .
Discussion
This study reports the first clinical use of capnodynamic assessment of CO (CO EPBF ) in human infants. The main result of our study was that CO EPBF appears to be a valid methodology to detect hemodynamic variations in children undergoing surgery. In the experimental setting, CO EPBF performed similarly to the gold standard comparator CO TS . These measures can, therefore, be viewed as potentially interchangeable measures of CO. Accessible and reliable assessment of CO in mechanically ventilated patients is of clinical interest in many areas. This is especially true in the context of paediatric anaesthesia and intensive care, where the options to assess CO are limited. To find a methodology that can be easily and safely applied both in adults and children would be of great value for optimising clinical care and, ultimately, patient safety. Such new methodologies should ideally be user-independent, have a minimal learning curve, not be prone to drift or require frequent recalibration, and also avoid the need for administration of ; n¼15 in clinical study, n¼9 in experimental study. Note that CO in the human study is age dependent causing a large range (cf. the reduced range in the animal study). CO, cardiac output; EBPF, effective pulmonary blood flow. additional fluid. Initial animal studies regarding the use of the capnodynamic concept of assessing CO and CO EPBF , hold promise in this regard. 3, 28 CO EPBF vs CO SSD in the clinical setting During baseline conditions the calculated precision of the two methodologies was found to be within generally acceptable limits. However, the clinical finding that CO SSD was unable to detect the expected reduction in CO in response to an increase of PEEP, a reduction that was readily detected by CO EPBF , was surprising considering the general acceptance regarding the use of CO SSD . The reason for this is most likely multifactorial. Determination of CO with CO SSD relies on an accurate measurement of the diameter of the aortic outflow tract, as this factor is incorporated in the equation as a square factor (area of the aortic opening¼pd 2 /4). Calculations made based on either the maximum, minimum, or mean measurement of the aortic outflow diameter were found to produce substantial differences in calculated CO SSD (data not shown), which also affected the agreement of the two methodologies (best agreement between the two methodologies when using the minimum value). Although this is an inherent problem, it cannot explain why CO SSD was unable to detect the expected reduction of CO in association with increased PEEP, as the diameter of the aortic outflow remains constant between measurements.
A more important factor in this context is that an increase in PEEP will cause a greater degree of lung inflation, which in turn alters the intrathoracic geometry. This circumstance necessitated minor changes of the transducer position to achieve adequate Doppler signalsdeven in very experienced hands. The matter of small differences in the angle of the ultrasound beam to the aortic blood flow is an established confounder using the CO SSD technique. 29 Further support for this explanation is that CO SSD readily detected the increase in CO caused by atropine. In this situation, the geometry of the thorax is constant between measurements and, thus, no adjustment of the ultrasound probe is required. In contrast to CO SSD, the assessment of CO EPBF is operatorindependent and remains unaffected by alterations in thoracic geometry. This robust technique is based solely on the accurate determination of exhaled CO 2 , with a rapid response time. 5 Arguably, it does also involve certain assumptions, including constant mixed venous CO 2 content during each nine breath analysis sequence, minimal pulmonary shunting and CO 2 content in capillary blood calculated from expired carbon dioxide and haemoglobin concentration. However, these assumptions appear to be reasonable based on previous studies. 3e5,30 A major limitation, however, is that CO EPBF can only be used in tracheally intubated and mechanically ventilated patients and, thus, cannot be used in awake patients.
CO EPBF vs CO TS in the animal laboratory setting
Because of to the variable performance of CO SSD in the clinical study, we also explored the same research protocol in a porcine laboratory model in order to compare the performance of CO EPBF with the gold standard measure CO TS . During baseline conditions, the calculated inherent precision of CO EPBF was similar to the clinical study, comparing well with the calculated precision associated with CO TS . A good agreement between CO EPBF and CO TS was observed at all time points of the study protocol (Fig. 4, Table 1 ). To be interchangeable in the context of CO assessments, by general consensus agreement between two methods <30% is required. 25 The overall agreement in this study between CO TS and CO EPBF was 31%, thus, being very close to fulfilling this criterion. From a practical perspective, especially in children where other options to measure CO are few, we suggest that CO TS and CO EPBF may be viewed as interchangeable techniques to measure CO. Although the concordance between laboratory and clinical studies differed, the lower concordance in the clinical study is chiefly attributable to the relatively poor performance of the CO SSD method rather than limitations of the CO EPBF technique. In previous CO EPBF animal studies, the concordance between CO EPBF and the comparator technique has been extremely high. 30 However, in these studies the hemodynamic alterations have been very substantial and, thus, the likelihood of concordance should be very high. From a clinical perspective, it may be more important to detect smaller changes in CO. Furthermore, ethical concerns limit more extreme haemodynamic alterations in a paediatric clinical investigation. Thus, the resulting hemodynamic changes caused by our research protocol were in the range of 15% compared with baseline, making determinations of concordance challenging. The method of determining concordance also involves an exclusion zone for more discrete random changes of CO. By restricting the exclusion zone to 10%, our protocol resulted in a limited number of data points to include in the concordance analysis, which is a limitation of the study. However, we believe a concordance rate for clinically relevant changes of CO of 64% merits further study. Most importantly, as the concordance rate was found to be 95% in the experimental study when using the gold standard comparator (CO TS ), the lower concordance rate in the clinical part of the study may be attributable to the variable CO SSD measures. In summary, this is the first clinical investigation using the CO EPBF technique. Our data show that CO EPBF represents a promising technology to detect minor to moderate CO changes in children undergoing anaesthesia. When validated in piglets, CO EPBF achieves very similar results compared with the gold standard CO TS . Continuous CO EPBF measurement may enable the early detection of haemodynamic trends, although this requires further clinical study.
